Canvas Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$385K Sell
2,978
-12
-0.4% -$1.41K 0.05% 167
2026
Q1
$362K Buy
2,990
+181
+6% +$20.9K 0.06% 157
2025
Q4
$296K Buy
+2,809
New +$264K 0.05% 164
2025
Q3
Sell
-2,762
Closed -$232K 223
2025
Q2
$232K Buy
+2,762
New +$220K 0.05% 183
2025
Q1
Sell
-2,760
Closed -$277K 195
2024
Q4
$277K Sell
2,760
-406
-13% -$41.9K 0.07% 136
2024
Q3
$360K Buy
3,166
+627
+25% +$74.5K 0.1% 112
2024
Q2
$293K Buy
2,539
+367
+17% +$47.3K 0.09% 113
2024
Q1
$272K Buy
2,172
+290
+15% +$35.7K 0.09% 112
2023
Q4
$223K Sell
1,882
-93
-5% -$9.65K 0.08% 118
2023
Q3
$203K Sell
1,975
-73
-4% -$7.87K 0.08% 119
2023
Q2
$223K Sell
2,048
-265
-11% -$30.1K 0.08% 122
2023
Q1
$266K Buy
2,313
+92
+4% +$9.93K 0.11% 117
2022
Q4
$242K Buy
+2,221
New +$227K 0.1% 128

Other funds holding MRK

Canvas Wealth Advisors's MRK Position: Q2 2026 in Review

Canvas Wealth Advisors reduced its Merck (MRK) stake by 0.4% in Q2 2026, selling an estimated $1.41K and leaving 2,978 shares worth $385K. The position accounts for 0.05% of the portfolio, ranked #167.

Canvas Wealth Advisors first reported a position in MRK in Q4 2022 and has held it in 13 quarters since. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Canvas Wealth Advisors held 2,978 shares of Merck worth $385K as of Q2 2026.
  • Canvas Wealth Advisors sold 12 Merck shares in Q2 2026, an estimated $1.41K.
  • Merck made up 0.05% of Canvas Wealth Advisors's portfolio in Q2 2026, its #167 holding.
  • Canvas Wealth Advisors first reported a position in Merck in Q4 2022 and has held it in 13 quarters since.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Canvas Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.